HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality
Investigating morbidity and mortality in an HIV/HCV‐coinfected population in care
View PublicationInvestigating morbidity and mortality in an HIV/HCV‐coinfected population in care
View PublicationInvestigating the importance of HIV blip magnitude on virologic rebound
View PublicationDescribing unique design features and investigational procedures that were applied to a CTN 173 to enhance HIV immunity
View PublicationEvaluating factors associated with discordance between the absolute CD4 cell count and the CD4 cell percentage in HIV/HCV-coinfected patients
View PublicationAssessing whether adding valproic acid to stable HAART could potentially reduce the size of the latent viral reservoir in CD4 T cells of chronically infected patients
View PublicationComparing the times to regimen failure according to nucleoside backbone in treatment-naive patients starting cART in a retrospective observational cohort study
View PublicationExamining the impact of ART interruption on liver fibrosis progression in co-infected adults
View PublicationInvestigating whether the use of ALVAC with Remune may induce anti-HIV responses capable of controlling viral replication
View Publication